Deutsche Bank Ag\ Spero Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.74 - $7.44 $10,274 - $103,304	-13,885 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$7.87 - $15.15 $13,048 - $25,118	-1,658 Reduced 10.67%	13,885 $121,000
Q4 2021 Feb 11, 2022	BUY	$13.09 - $18.77 $10,210 - $14,640	780 Added 5.28%	15,543 $249,000
Q3 2021 Nov 04, 2021	SELL	$13.03 - $19.51 $5,889 - $8,818	-452 Reduced 2.97%	14,763 $272,000
Q2 2021 Aug 11, 2021	BUY	$12.22 - $15.79 $15,421 - $19,926	1,262 Added 9.04%	15,215 $213,000
Q1 2021 May 13, 2021	SELL	$13.23 - $21.48 $16,391 - $26,613	-1,239 Reduced 8.16%	13,953 $205,000
Q4 2020 Feb 16, 2021	BUY	$11.65 - $22.07 $80,571 - $152,636	6,916 Added 83.57%	15,192 $294,000
Q3 2020 Nov 12, 2020	BUY	$8.96 - $14.12 $6,737 - $10,618	752 Added 9.99%	8,276 $92,000
Q2 2020 Aug 13, 2020	BUY	$7.27 - $14.18 $29,479 - $57,499	4,055 Added 116.89%	7,524 $102,000
Q1 2020 May 14, 2020	SELL	$5.27 - $10.41 $23,509 - $46,439	-4,461 Reduced 56.25%	3,469 $28,000
Q4 2019 Feb 14, 2020	BUY	$9.46 - $12.16 $47,725 - $61,347	5,045 Added 174.87%	7,930 $76,000
Q3 2019 Nov 14, 2019	SELL	$9.01 - $12.55 $43,716 - $60,892	-4,852 Reduced 62.71%	2,885 $30,000
Q2 2019 Aug 14, 2019	SELL	$10.25 - $14.36 $22,724 - $31,836	-2,217 Reduced 22.27%	7,737 $88,000
Q1 2019 May 15, 2019	SELL	$6.26 - $13.31 $6,742 - $14,334	-1,077 Reduced 9.76%	9,954 $127,000
Q4 2018 Feb 14, 2019	SELL	$5.69 - $11.28 $47,175 - $93,522	-8,291 Reduced 42.91%	11,031 $67,000
Q3 2018 Dec 21, 2021	BUY	$9.69 - $17.79 $21,666 - $39,778	2,236 Added 13.09%	19,322 $203,000
Q3 2018 Nov 14, 2018	BUY	$9.69 - $17.79 $43,721 - $80,268	4,512 Added 35.88%	17,086 $179,000
Q2 2018 Apr 21, 2020	BUY	$10.41 - $17.85 $21,069 - $36,128	2,024 Added 19.18%	12,574 $184,000
Q2 2018 Aug 14, 2018	BUY	$10.41 - $17.85 $28,346 - $48,605	2,723 Added 34.79%	10,550 $154,000
Q1 2018 Oct 18, 2019	BUY	$9.96 - $14.61 $13,754 - $20,176	1,381 Added 21.42%	7,827 $110,000
Q1 2018 May 15, 2018	SELL	$9.96 - $14.61 $68,196 - $100,034	-6,847 Reduced 51.51%	6,446 $91,000
Q4 2017 Feb 14, 2018	BUY	$10.43 - $14.75 $138,645 - $196,071	13,293	13,293 $155,000

Others Institutions Holding SPRO

# of Institutions

Shares Held

13.9M

Call Options Held

200

Put Options Held

200

Anson Funds Management LP Dallas, TX

3.75M
Shares

$3.56 Million
0.6% of portfolio
Vanguard Group Inc Valley Forge, PA

1.76M
Shares

$1.68 Million
0.0% of portfolio
Atlas Venture Associates Ix, LLC Boston, MA

1.35M
Shares

$1.29 Million
14.54% of portfolio
Acadian Asset Management LLC Boston, MA

1.07M
Shares

$1.02 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

975K
Shares

$925,920
0.0% of portfolio

View Full List

About Spero Therapeutics, Inc.

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $33.3M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

More about SPRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account